Proven Aspergillus flavus pulmonary aspergillosis in a COVID-19 patient: A case report and review of the literature

Mycoses. 2021 Aug;64(8):809-816. doi: 10.1111/myc.13255. Epub 2021 Mar 2.

Abstract

Severe COVID-19 patients complicated with aspergillosis are increasingly reported. We present a histopathological proven case of fatal COVID-19-associated pulmonary aspergillosis (CAPA), due to Aspergillus flavus. This report and existing published literature indicate diagnostic challenges and poor outcomes of CAPA in ICU patients.

Keywords: Aspergillosis; COVID-19; Immunocompetent.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Aspergillus flavus / isolation & purification
  • Aspergillus flavus / pathogenicity*
  • COVID-19 / complications*
  • Humans
  • Male
  • Pulmonary Aspergillosis / diagnostic imaging
  • Pulmonary Aspergillosis / etiology*
  • Pulmonary Aspergillosis / microbiology
  • Radiography, Thoracic
  • SARS-CoV-2*
  • Tomography, X-Ray Computed